Report Shows Theranos Testing Plagued by Problems
Federal regulators say the blood-testing company used poorly trained workers and mishandled blood samples.
Report Shows Theranos Delivered Inaccurate Test Results
Federal regulators say the blood-testing company also used poorly trained workers and mishandled blood samples.
Study of Theranos Medical Tests Finds Irregular Results
A report published in The Journal of Clinical Investigation compared blood test results from Theranos with some from two large…
Lawyer for Turing Said He Warned Against Drug Price Increase
The lawyer, Howard Dorfman, told a Senate panel that he told Martin Shkreli that the move would negatively affect Turing’s…
Test of Zika-Fighting Genetically Engineered Mosquitoes Gets Tentative F.D.A. Approval
A trial in the Florida Keys has been tentatively approved, but public comment must be assessed first by the agency.
Genetic Test Firm to Put Customers’ Data in Public Domain
Ambry Genetics is expected to announce on Tuesday that it will put information from 10,000 customers into a publicly available…
A Biotech Evangelist Seeks a Zika Dividend
A diverse biotechnology company hopes its genetically engineered mosquitoes can help stop the spread of a devastating virus. But that’s…
Valeant Pharmaceuticals Chief Returns From Medical Leave
J. Michael Pearson is returning as chief executive after two months, but is giving up his role as chairman.
Martin Shkreli Invokes the Fifth Amendment in House Appearance
Lawmakers questioned drug company executives Thursday, focusing on pricing practices, and criticized Martin Shkreli for refusing to answer questions.
Drug Firms Expected to Defend Huge Price Increases in House Testimony
In prepared testimony, a Valeant Pharmaceuticals executive says that hospitals, not patients, are affected by the increases.